Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Becanex GmbH logo — Producer of the world's only plant identical cannabis extrac...

Becanex GmbH

Producer of the world's only plant identical cannabis extract - Don't smoke - drop!

Founded 2018 Germany Berlin, Germany 12 employees Seed Total: $765.00K

General Information

Company Name Becanex GmbH
Founded Year 2018
Location Germany Berlin, Germany +1
Employees 12
Funding Stage Seed
Social

Get notified when Becanex GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Becanex GmbH

Becanex is a Berlin-based startup, founded in 2018, with a compelling vision to transform the medical cannabis industry. The company's innovative one-step-extraction process stands out, aiming to disrupt the market by producing a plant-identical cannabis extract that mirrors the plant profile of cannabis strains while eliminating undesirable components such as waxes and chlorophyll. This has immense potential to offer patients and physicians the benefits of cannabis consumption without the associated harms of traditional smoking methods. In January 2021, Becanex secured an impressive €765.00KSeed Round investment from IBB Invest. This injection of funds signifies a validation of their groundbreaking approach and demonstrates investor confidence in the potential of the company. Becanex's strategic partnerships with leaders in drug delivery systems further highlight their commitment to optimizing dosing and delivery methods, allowing physicians to prescribe tailored solutions to meet the unique needs of their patients. The company's decade-long experience in cannabinoid extraction provides a solid foundation for entering the medical market by aligning with legal, medical, and patient requirements. With their very own pharma-GMP production facility in Berlin-Adlershof and an R&D department on the campus of Wageningen University, Becanex is positioned to make a significant impact in the burgeoning medical cannabis sector. As Becanex gears up to finalize its transition to the medical cannabis market in 2023, its journey from a small extraction prototype in a Dutch basement to a cutting-edge high-tech startup showcases its remarkable evolution. With a focus on creating a positive impact on the medical cannabis industry and addressing patient needs, Becanex is poised for success in this rapidly growing sector.

Taxonomy: cannabinoid extraction, white labeling, private labeling, infusion, Europe, science-based approach, patented extraction method, broad spectrum of cannabinoids, terpenes, supply services, consultation services, premium natural hemp flavoring, food products, innovation, mild extraction

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
06 Jan 2021

FAQ About Becanex GmbH

Producer of the world's only plant identical cannabis extract - Don't smoke - drop!
Becanex GmbH was founded in 2018.
Becanex GmbH is headquartered in Berlin, Germany.
Becanex GmbH has approximately 12 employees.
Becanex GmbH has completed 1 funding round, raising a total of $765.00K. The latest funding stage is Seed.

We're actively collecting intelligence on Becanex GmbH.

Track Becanex GmbH to get notified

Don't just browse. Track.

Signal Tracker monitors Becanex GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy